|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Kapa Biosystems and VWR International, Inc. Sign Agreement to Distribute Next-Generation DNA Amplification Reagents in North America
1/12/2010 10:29:30 AM
WOBURN, Mass.--(BUSINESS WIRE)--Kapa Biosystems and VWR International, LLC announced today that they have entered into a non-exclusive North American distribution agreement for Kapa Biosystems' line of next-generation PCR reagents. Kapa Biosystems employs a high-throughput molecular evolution technology platform to engineer DNA-modifying enzymes for applications in DNA amplification, next-generation sequencing, and molecular diagnostics. Under the terms of the agreement, VWR has the rights to distribute Kapa Biosystems' portfolio of innovative products for applications such as high fidelity PCR, fast PCR, long range PCR, whole blood PCR, crude sample PCR, and single protocol PCR. VWR, a global laboratory supply and distribution company with worldwide sales in excess of $3.7 billion in 2008, enables the advancement of the world’s most critical research through the distribution of a highly diversified product line to most of the top pharmaceutical and biotech companies, as well as industrial, educational and governmental organizations.
|
|
|
|
|
|
|
|
|
|
|